Form 8-K - Current report:
SEC Accession No. 0001144204-17-051344
Filing Date
2017-10-04
Accepted
2017-10-04 14:15:09
Documents
1
Period of Report
2017-10-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v476474_8k.htm 8-K 15447
  Complete submission text file 0001144204-17-051344.txt   16827
Mailing Address 1311 PINEVIEW DRIVE SUITE 501 MORGANTOWN WV 26505
Business Address 1311 PINEVIEW DRIVE SUITE 501 MORGANTOWN WV 26505 304 292-2226
Protea Biosciences Group, Inc. (Filer) CIK: 0001335103 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51474 | Film No.: 171121199
SIC: 2834 Pharmaceutical Preparations